Industries
Healthcare and life sciences
Healthcare operators fund diagnostic and treatment equipment, site development and acquisitions. Lenders assess regulatory standing, payer mix and occupancy alongside financial performance.
Healthcare and life sciences
- Diagnostic and treatment equipment finance
- Clinic and practice acquisition funding
- Site development and fit-out finance
- Common structures
- Equipment lease/loan, acquisition finance, site development finance
- Typical facility size
- £150,000 – £20 million
- Indicative pricing
- Base rate plus 2–7 per cent, structure-dependent
- Security
- Equipment charge, debenture, practice goodwill in acquisitions
- Time to funding
- 3–8 weeks, longer where regulatory approval is pending
Regulated income streams and long asset lives
Healthcare operators — clinics, diagnostic centres, care providers and life sciences businesses — combine capital-intensive equipment with revenue that is often shaped by payer mix: insurers, national health systems, or private patients. Equipment such as imaging or diagnostic systems is expensive, has a long useful life, and typically requires periodic upgrade to remain clinically and commercially competitive.
Growth is frequently pursued through acquisition of clinics or practices rather than organic build-out, since regulatory licensing and patient relationships take time to establish. This makes acquisition funding, alongside equipment finance, a recurring requirement across the sector.
Structures suited to healthcare operators
Equipment finance, structured as a lease or loan secured against the asset, is the standard route to diagnostic and treatment equipment, often supported by manufacturer or vendor finance programmes. Site development and fit-out finance suits new clinic or facility build-out, sized against projected occupancy or patient volume.
Practice and clinic acquisition is typically funded through a blend of senior debt against normalised earnings and, where relevant, vendor financing from the selling practitioner. Cash-flow lending against contracted payer income is available to more established operators but generally requires a demonstrable trading record.
What lenders scrutinise
Regulatory standing — licensing, accreditation and any history of compliance action — is reviewed closely, since it directly affects the operator's ability to continue trading. Payer mix and reimbursement timelines matter: a business dependent on slow-paying public payers is assessed differently to one with predominantly private or insured patients.
Occupancy or utilisation rates for clinics and treatment facilities, clinician retention, and referral pathways feature heavily in underwriting for both equipment and acquisition finance, alongside conventional financial diligence.
Where applications typically fail
Early-stage clinics without a trading record frequently approach cash-flow lenders when equipment or fit-out finance, sized against the asset rather than trading history, would be a better fit and more readily available. A second common issue is underestimating the regulatory lead time on licensing, which can delay drawdown even after finance is agreed in principle.
In acquisition financing, incomplete disclosure of clinician contracts or referral arrangements — which underpin the earnings being acquired — is a frequent source of delay once due diligence begins.
How GFG runs the process
GFG matches the funding structure to the stage of the business: equipment or fit-out finance for early-stage and expanding clinics, cash-flow and acquisition finance once a trading record and payer mix are established. Regulatory status and licensing timelines are reviewed upfront to avoid delay between agreement and drawdown.
Are early-stage clinics fundable?
Equipment and fit-out finance is available; unsecured cash-flow lending typically requires a trading record.
Can a start-up clinic get funding before it has patients?
Equipment and fit-out finance is generally available at the pre-revenue stage because it is secured against the asset or premises rather than trading income. Unsecured cash-flow lending typically requires an established trading record and is not usually accessible to a clinic before it opens.
How does payer mix affect the funding available to a healthcare business?
A higher proportion of private or promptly-settled insured income is viewed favourably because it produces more predictable cash flow. Heavy reliance on slower-paying public payers is not disqualifying but may result in more conservative facility sizing or a requirement for additional working capital headroom.
Is funding available to acquire a medical or dental practice?
Yes, acquisition funding for practices is a well-established market, usually structured as senior debt against the practice's normalised earnings, sometimes supported by vendor financing. Lenders will review clinician retention and patient list continuity as part of underwriting.
Do regulatory approvals affect the funding timeline?
Yes. Equipment or facility finance can usually be arranged in parallel with a licensing application, but funds are typically not drawn until the relevant regulatory approval is confirmed, since this affects the operator's ability to generate the income the facility relies on.
Can imaging or diagnostic equipment be refinanced once installed?
Yes, sale and leaseback of installed diagnostic equipment is a recognised way to release capital, provided the equipment retains resale value and remains within its useful economic life as assessed by the financing lessor.